 general meeting and disclosed in note 4 on page 45 in the annual report 202 4. 
Development during 2024 
 
The CEO summarizes the company’s overall performance in his statement on pages 4-5 in the annual 
report 2024. 
The company’s remuneration guidelines: scope, purpose and deviations 
A prerequisite for the successful implementation of the company’s business strategy and safeguarding of its long- term interests, including its sustainability, is that the company can recruit 
and retain qualified personnel. For this, the c ompany needs to be able to offer competitive 
remuneration. The company’s remuneration guidelines enable the company to offer executives a competitive total remuneration. Under the remuneration guidelines, executive remuneration shall 
be on market terms and may consist of the following components: fixed cash salary, variable cash 
remuneration, pension benefits and other benefits. The variable cash remuneration can be linked to 
both financial or non -financial cri mance measures for the CEO’s variable remuneration have been established to deliver the 
company’s strategy and to encourage behavior which is in the long- term interest of the company . In 
the determination of performance measures, the strategic objectives and short-term and long- term 
business priorities for 2024 have been taken into account. The non -financial performance measures 
further contribute to alignment with sustainability as well as the company values. 
Table 2 – Performance of the CEO in the reported financial year: variable cash remuneration 
 
Comparative information on the change of remuneration and company performance 
Table 3 – Change of remuneration and company performance over the last five reported financial 
years (RFY) (kSEK) Name of 
director 
(position) Description of the criteria related to 
the remuneration component Relative weighting of the performance 
criteria a) Measured performance and 
b) actual award/ remuneration 
outcome 
Jens 
Lindberg Target 1 s 
Lindberg Target 1 2024 – Clinical development 45 % a) 45 % 
b) kSEK 585 
Target 2 2024 – Financing 30 % a) 0 % 
b) kSEK 0 
Target 3 2024 – Business development 25 % a) 0 % 
b) kSEK 0

4 
 2024 2023 2022 2021 2020 
CEO remuneration 3,938 4,228 3,4971) 3,0471) 3,1661) 
Change in remuneration (kSEK) vs previous year -290 
(-7%) 730 
(21%) 450 
(15%) -119 
(-4%) 515 
(19%) 
Group operating profit -127,341 -91,414 -87,354 -62,118 -42,900 
Change in operating profit vs previous year -35,927 
(-39%) -4,060 
(-5%) -25,236 
(-41%) -19,218 
(-45%) 83,079 
(66%) 
Average remuneration on a full time equivalent basis of 
employees of the parent company2) 3) 1,033 1,007 1,028 1,154 888 
Change vs previous year 25 
(3%) -20 
(-2%) -127 
(-11%) 226 
(30%) N/A3) 
 
1) The company has had two different CEO s during the years 2022, 2021 and 2020. Including extraordinary items . 
2) Excluding members of the group executive management 
3) Not applicable due to reorganizations